These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2496460)

  • 41. Alternate calcitonin and etidronate disodium therapy for Paget's bone disease.
    Perry HM; Droke DM; Avioli LV
    Arch Intern Med; 1984 May; 144(5):929-33. PubMed ID: 6424594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R; Holz G; Minne H; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
    [No Abstract]   [Full Text] [Related]  

  • 43. APD in Paget's disease of bone. Role of the mononuclear phagocyte system?
    Bijvoet OL; Frijlink WB; Jie K; van der Linden H; Meijer CJ; Mulder H; van Paassen HC; Reitsma PH; te Velde J; de Vries E; van der Wey JP
    Arthritis Rheum; 1980 Oct; 23(10):1193-204. PubMed ID: 6448605
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans).
    Altman RD; Johnston CC; Khairi MR; Wellman H; Serafini AN; Sankey RR
    N Engl J Med; 1973 Dec; 289(26):1379-84. PubMed ID: 4201876
    [No Abstract]   [Full Text] [Related]  

  • 46. Alterations in vitamin D metabolites during treatment of Paget's disease of bone with calcitonin or etidronate.
    Devlin RD; Gutteridge DH; Prince RL; Retallack RW; Worth GK
    J Bone Miner Res; 1990 Nov; 5(11):1121-6. PubMed ID: 2125401
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day).
    Alexandre CM; Chapuy MC; Vignon E; Edouard C; Johnston CC; Meunier PJ
    Clin Orthop Relat Res; 1983 Apr; (174):193-205. PubMed ID: 6403270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
    Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
    J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
    Sieghart S
    Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
    Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
    Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of Paget's disease of bone.
    Singer FR
    Postgrad Med; 1975 Mar; 57(3):117-20. PubMed ID: 123333
    [No Abstract]   [Full Text] [Related]  

  • 53. [A single infusion of Pamidronate (APD) in Paget's disease of bone].
    Thiébaud D; Jaeger P; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1989 Jan; 119(3):71-4. PubMed ID: 2711157
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 55. [Treatment of Paget's disease with low dose sodium etidronate (5mg/kg/day). Occurrence of reversible transient suspected leukopenia].
    Reginster JY; Gritten C; Diverse P; Hauwaert PC; Crielaard JM; Halleux R; Franchimont P
    Rev Rhum Mal Osteoartic; 1985 Mar; 52(3):145-50. PubMed ID: 3923603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.
    Adami S; Salvagno G; Guarrera G; Montesanti F; Garavelli S; Rosini S; Lo Cascio V
    Calcif Tissue Int; 1986 Oct; 39(4):226-9. PubMed ID: 2947663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Calcitonin nasal spray for Paget's disease of the bone].
    Luboshitzky R; Bar-Shalom R
    Harefuah; 1995 Mar; 128(6):358-62, 399. PubMed ID: 7750816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.
    Muff R; Dambacher MA; Perrenoud A; Simon C; Fischer JA
    Am J Med; 1990 Aug; 89(2):181-4. PubMed ID: 2382666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effects of an antiviral drug, inosiplex, and diphosphonates in Paget's disease of bone.
    Kanis JA; Preston CJ; Beard DJ; Beneton M; Harris S; Russell RG
    Bone; 1985; 6(2):69-72. PubMed ID: 2409999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.